--McKesson Unveils 15% Jump in Quarterly Dividends to $0.71 a Share From $0.62-March 2024-www.financetom.com

--McKesson Unveils 15% Jump in Quarterly Dividends to $0.71 a Share From $0.62

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--McKesson Unveils 15% Jump in Quarterly Dividends to $0.71 a Share From $0.62

Aug 7, 2024 2:05 PM

04:45 PM EDT, 08/07/2024 (MT Newswires) --

Price: 577.10, Change: -40.41, Percent Change: -6.54

Previous page： --PPG Industries Raises Quarterly Dividend by $0.03 Per Share to $0.68, Payable on Sept. 12 to Shareholders of Record on Aug. 12 Next page： Update: D.R. Horton Shares Jump After Fiscal Q3 Beat

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--PPG Industries Raises Quarterly Dividend by $0.03 Per Share to $0.68, Payable on Sept. 12 to Shareholders of Record on Aug. 12

Jul 18, 2024

10:17 AM EDT, 07/18/2024 (MT Newswires) -- Price: 135.01, Change: +1.25, Percent Change: +0.93 ...

Update: D.R. Horton Shares Jump After Fiscal Q3 Beat

Jul 18, 2024

10:20 AM EDT, 07/18/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.) D.R. Horton ( DHI ) shares were up 11.5% in recent Thursday trading after the company reported better-than-expected fiscal Q3 results. The homebuilder reported fiscal Q3 earnings of $4.10 per diluted share, up from $3.90 a year earlier. Analysts polled...

Apple in talks to license more Hollywood films, Bloomberg News reports

Jul 18, 2024

July 18 (Reuters) - Apple ( AAPL ) is in talks to license more films from Hollywood studios to boost its portfolio on Apple TV+, Bloomberg News reported on Thursday, citing people familiar with the matter. ...

Neurocrine Biosciences Rolls Out Ingrezza Sprinkle Capsules to Treat Tardive Dyskinesia, Chorea With Huntington's Disease

Jul 18, 2024

10:21 AM EDT, 07/18/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Thursday it has launched a new sprinkle formulation of Ingrezza capsules to treat adults with tardive dyskinesia and chorea associated with Huntington's disease, a neurodegenerative disorder. Tardive dyskinesia and chorea are involuntary movement disorders and the availability of a drug that can be sprinkled on soft food...